1-naphthylamine has been researched along with Affective Disorders, Psychotic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
Atala, KD; Baer, L; Beer, DA; Eisen, JL; Phillips, KA; Rasmussen, SA | 1 |
2 trial(s) available for 1-naphthylamine and Affective Disorders, Psychotic
Article | Year |
---|---|
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
The Brown Assessment of Beliefs Scale: reliability and validity.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Awareness; Brief Psychiatric Rating Scale; Delusions; Factor Analysis, Statistical; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Severity of Illness Index; Somatoform Disorders; Tape Recording; Treatment Outcome | 1998 |
1 other study(ies) available for 1-naphthylamine and Affective Disorders, Psychotic
Article | Year |
---|---|
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |